GEVO vs MAXN Stock Comparison
MAXN currently leads GEVO in this stock comparison, with AIQ scores of 61 vs 43. The clearest difference is value.
What is the main difference between GEVO and MAXN?
MAXN leads the current stock comparison as Maxeon Solar Technologies, Ltd., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Gevo, Inc. vs Maxeon Solar Technologies, Ltd.
MAXN leads
MAXN leads by 18 AIQ points, primarily on Value and Quality.
Competitive: 3 of 6 evidence groups support MAXN.
Gevo, Inc.
Maxeon Solar Technologies, Ltd.
The Algovestiq AIQ Score currently favors MAXN over GEVO, 61 versus 43 as of Oct 31, 2026. MAXN's advantage is driven primarily by stronger value and quality. MAXN also shows the weaker technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor MAXN today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. MAXN lead: Stable — the AIQ differential has held near 18 points over 30 sessions.
Compare Gevo, Inc. and Maxeon Solar Technologies, Ltd. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare GEVO and MAXN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value55 vs 75MAXN +20
- Quality40 vs 50MAXN +10
- Risk Resilience53 vs 54Even
3 of 6 evidence groups favor MAXN. MAXN’s edge is concentrated in value and quality.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Risk Resilience -1
No signal started or stopped since the prior session; its 4 active signals are unchanged.
No factor moved materially.
No signal started or stopped since the prior session.
MAXN's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — GEVO and MAXN both carry a full feed there.
The central trade-off
MAXN (Maxeon Solar Technologies, Ltd.): the stronger current systematic profile, led by value and quality.
GEVO (Gevo, Inc.): the counter-case, on fundamentals, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
MAXNMAXN on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EvenGrowth figures are not covered for both names.
Value
MAXNMAXN on the peer-relative Value factor, by 20 points.
Momentum
EvenThe two are level on Momentum.
Lower downside
GEVOGEVO carries the lower 1-month annualized volatility.
Analyst upside
MAXNMAXN on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | GEVO | MAXN | Note |
|---|---|---|---|
| Implied upside to target | +104% | +376.2% | MAXN has more room |
| Target dispersion | +72.5% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 3 | 1 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor MAXN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | MAXN | 43 vs 61 |
| Fundamentals | GEVOon balance | TTM ROE -51.4% vs 20%; gross margin 42.9% vs -39.2%; operating margin -104.5% vs -176.3% — GEVO takes 2 of 3 decided legs, not all of them |
| Valuation | MAXN | Value 55 vs 75 |
| Technicals | GEVO | Price vs 50-day -12.1% vs -88.6%; vs 200-day -29.3% vs -37.9% |
| Risk Resilience | Even | Risk Resilience 53 vs 54 |
| Analyst expectations | MAXN | Target upside 104% vs 376.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of GEVO and MAXN and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 18 points. (supports the conclusion holding)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on MAXN.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28MAXN lead: Stable — the AIQ differential has held near 18 points over 30 sessions.
- Today
- MAXN +18
- 43 vs 61
- 7 sessions ago
- MAXN +17
- 44 vs 61
- 30 sessions ago
- MAXN +18
- 43 vs 61
- 90 sessions ago
- GEVO +5
- 53 vs 48
The lead changed hands 19 times in this window, most recently on Sep 11 when MAXN moved ahead of GEVO.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish / 1 neutral, conflicted
Only GEVO
- Death Cross Active — bearish, trend, long horizon (21.43%)
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.25%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
No active signals
No signal that the other name lacks.
GEVO is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +3.31%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1GEVO closes the Value gap — currently 20 points behind, the largest single contributor to MAXN's edge.
- 2GEVO's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3MAXN starts generating bearish momentum or trend signals.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
GEVO leads on balance| Metric | GEVO | MAXN |
|---|---|---|
| Revenue growth (YoY) | 8.3% | 0% |
| EPS growth (YoY) | -7.2% | 0% |
| Gross margin | 42.9% | -39.2% |
| Operating margin | -104.5% | -176.3% |
| Return on equity (TTM) | -51.4% | 20% |
| Debt to equity | 0.62 | -0.98 |
Performance
GEVO leads 3 of 3 windows| Metric | GEVO | MAXN |
|---|---|---|
| 1 week (5 sessions) | 9.9% | -17.7% |
| 1 month (20 sessions) | -7.2% | -30.7% |
| 3 months (63 sessions) | -20.3% | — |
| 6 months (126 sessions) | -35.8% | — |
| Year to date | -39% | -52.2% |
| 1 year (252 sessions) | -50.6% | — |
Technicals
GEVO has the stronger structure| Metric | GEVO | MAXN |
|---|---|---|
| RSI (14) | 34.1 | 15.3 |
| ADX (14) | 38.7 | 22.2 |
| Price vs 50-day | -12.1% | -88.6% |
| Price vs 200-day | -29.3% | -37.9% |
| Volatility (1M, annualized) | 47.9% | 143.7% |
Risk
Split| Metric | GEVO | MAXN |
|---|---|---|
| Beta | 0.91 | 1.55 |
| Sharpe ratio | -0.81 | -1.17 |
| Sortino ratio | -1.22 | -1.68 |
| Max drawdown | -60% | -82.4% |
| Current drawdown | -56% | -80.5% |
| Annualized volatility | 61.7% | 144.7% |
| Value at risk (95%) | -5.9% | -12.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, GEVO or MAXN?
On the Algovestiq AIQ Score, MAXN is the stronger of the two as of Oct 31, 2026, scoring 61 against GEVO's 43. The edge comes from value and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is GEVO or MAXN the better buy right now?
MAXN carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor MAXN over GEVO?
The composite weights Quality, Value, Momentum and Risk Resilience. MAXN leads Value by 20 points; MAXN leads Quality by 10 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, GEVO or MAXN?
Analyst price targets imply +104% upside for GEVO and +376.2% for MAXN, so the Street currently favors MAXN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, GEVO or MAXN?
MAXN is the better-valued of the two on the peer-relative Value factor. MAXN on the peer-relative Value factor, by 20 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, GEVO or MAXN?
Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, GEVO or MAXN?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, GEVO or MAXN?
GEVO is the more resilient of the two, so the other name carries the higher downside risk. GEVO carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is GEVO more profitable than MAXN?
The profitability evidence is mixed: gross margin 42.9% vs -39.2%; operating margin -104.5% vs -176.3%; ttm roe -51.4% vs 20%. GEVO leads on two measures and MAXN on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is MAXN's lead over GEVO getting stronger or weaker?
MAXN lead: Stable — the AIQ differential has held near 18 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has changed hands 19 times in that window, most recently on 2026-09-11, when MAXN moved ahead of GEVO.
What would change the GEVO vs MAXN verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: GEVO closes the Value gap — currently 20 points behind, the largest single contributor to MAXN's edge; GEVO's Death Cross Active resolves — a bearish trend rule currently active against it; MAXN starts generating bearish momentum or trend signals; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about GEVO and MAXN?
GEVO: 1 bullish / 2 bearish / 1 neutral, conflicted. MAXN: No active signals. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on GEVO is Death Cross Active (bearish, long horizon).
Compare GEVO and MAXN with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.